NCT03252808 2024-12-09
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Takara Bio Inc.
Phase 1 Active not recruiting
Takara Bio Inc.
Hallym University Medical Center
National Health Research Institutes, Taiwan
Yonsei University
Samsung Medical Center
AstraZeneca